Mazzo David J
Insider CIK 1334549 · RGDO President and CEO, Director · PSDV Director · CUR Director · NBS President & CEO, Director · AVNR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LSTA LISATA THERAPEUTICS, INC. | A Award deriv | 2026-01-09 | 2026-01-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2026-01-09 | 2026-01-13 | 81,000 | — | $0 | 352,986 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2026-01-09 | 2026-01-13 | 10,503 | $1.97 | $20.7K | 342,483 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2026-01-09 | 2026-01-13 | 10,515 | $1.97 | $20.7K | 331,968 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2026-01-09 | 2026-01-13 | 7,854 | $1.97 | $15.5K | 311,890 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2026-01-09 | 2026-01-13 | 12,224 | $1.97 | $24.1K | 319,744 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2025-01-10 | 2025-01-13 | 3,106 | $3.73 | $11.6K | 264,690 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award deriv | 2025-01-09 | 2025-01-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2025-01-09 | 2025-01-13 | 9,414 | $3.80 | $35.8K | 285,738 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2025-01-09 | 2025-01-13 | 10,925 | $3.80 | $41.5K | 274,813 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2025-01-09 | 2025-01-13 | 7,017 | $3.80 | $26.7K | 267,796 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2025-01-09 | 2025-01-13 | 81,000 | — | $0 | 295,152 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2024-10-01 | 2024-10-02 | 26,964 | $2.93 | $79.0K | 211,834 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2024-10-01 | 2024-10-02 | 58,000 | $2.93 | $169.9K | 238,798 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2024-01-11 | 2024-01-12 | 1,026 | $2.99 | $3.1K | 174,766 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2024-01-10 | 2024-01-11 | 3,470 | $3.00 | $10.4K | 175,792 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award deriv | 2024-01-09 | 2024-01-11 | 47,000 | — | $0 | 47,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2024-01-09 | 2024-01-11 | 12,203 | $3.08 | $37.6K | 187,105 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2024-01-09 | 2024-01-11 | 7,843 | $3.08 | $24.2K | 179,262 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2024-01-09 | 2024-01-11 | 94,000 | — | $0 | 199,308 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2023-01-13 | 2023-01-17 | 397 | $3.65 | $1.4K | 96,543 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2023-01-11 | 2023-01-12 | 1,030 | $3.20 | $3.3K | 96,940 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2023-01-10 | 2023-01-11 | 3,470 | $3.20 | $11.1K | 97,970 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award deriv | 2023-01-09 | 2023-01-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2023-01-09 | 2023-01-11 | 60,000 | — | $0 | 109,285 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | F Tax w/h | 2023-01-09 | 2023-01-11 | 7,845 | $3.00 | $23.5K | 101,440 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2022-09-01 | 2022-09-02 | 69,742 | $0.50 | $34.9K | 739,444 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2022-09-01 | 2022-09-02 | 150,000 | $0.50 | $75.0K | 809,186 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2022-01-14 | 2022-01-18 | 6,611 | $0.82 | $5.4K | 631,065 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2022-01-13 | 2022-01-18 | 6,471 | $0.81 | $5.2K | 637,676 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2022-01-11 | 2022-01-12 | 16,740 | $0.87 | $14.6K | 644,147 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award deriv | 2022-01-10 | 2022-01-12 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2022-01-10 | 2022-01-12 | 401,000 | — | $0 | 717,297 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2022-01-10 | 2022-01-12 | 56,410 | $0.92 | $51.9K | 660,887 | SEC↗ |
| SNCA Seneca Biopharma, Inc. | A Award deriv | 2021-04-01 | 2021-04-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2021-01-14 | 2021-01-15 | 5,936 | $1.56 | $9.3K | 299,505 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2021-01-13 | 2021-01-15 | 6,425 | $1.55 | $10.0K | 305,441 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2021-01-13 | 2021-01-15 | 21,787 | $1.55 | $33.8K | 311,866 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2021-01-13 | 2021-01-15 | 39,000 | — | $0 | 333,653 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award deriv | 2021-01-11 | 2021-01-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2021-01-11 | 2021-01-12 | 16,621 | $1.59 | $26.4K | 294,653 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2021-01-11 | 2021-01-12 | 119,000 | — | $0 | 311,274 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2021-01-08 | 2021-01-12 | 4,726 | $1.60 | $7.6K | 192,274 | SEC↗ |
| SNCA Seneca Biopharma, Inc. | A Award deriv | 2020-04-03 | 2020-04-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 19,000 | — | $0 | 19,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 33,500 | — | $0 | 33,500 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2020-01-14 | 2020-01-15 | 6,382 | $3.38 | $21.6K | 186,382 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award deriv | 2020-01-13 | 2020-01-15 | 69,000 | — | $0 | 69,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2020-01-13 | 2020-01-15 | 46,000 | — | $0 | 199,010 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2020-01-13 | 2020-01-15 | 6,246 | $3.28 | $20.5K | 192,764 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2020-01-08 | 2020-01-09 | 4,522 | $2.83 | $12.8K | 153,010 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2019-10-09 | 2019-10-11 | 33,333 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2019-10-09 | 2019-10-11 | 33,333 | $1.95 | $65.0K | 200,083 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2019-09-06 | 2019-09-10 | 417 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2019-09-06 | 2019-09-10 | 417 | — | $0 | 166,750 | SEC↗ |
| CUR Neuralstem, Inc. | A Award deriv | 2019-07-01 | 2019-10-11 | 10,106 | — | $0 | 10,106 | SEC↗ |
| CUR Neuralstem, Inc. | A Award deriv | 2019-07-01 | 2019-07-03 | 187,510 | — | $0 | 187,510 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2019-06-25 | 2019-06-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2019-06-21 | 2019-06-24 | 8,333 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2019-06-21 | 2019-06-24 | 8,333 | — | $0 | 166,333 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2019-03-29 | 2019-04-01 | 20,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2019-03-29 | 2019-04-01 | 20,000 | $1.77 | $35.4K | 158,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award deriv | 2019-01-14 | 2019-01-16 | 71,000 | — | $0 | 71,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2019-01-14 | 2019-01-16 | 6,301 | — | $0 | 151,405 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2019-01-14 | 2019-01-16 | 47,000 | — | $0 | 157,706 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2019-01-08 | 2019-01-10 | 4,478 | $4.64 | $20.8K | 110,706 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-09-06 | 2018-09-10 | 417 | — | $0 | 417 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-09-06 | 2018-09-10 | 1,667 | — | $0 | 1,667 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2018-06-27 | 2018-06-29 | 17,500 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2018-06-27 | 2018-06-29 | 17,500 | — | $0 | 138,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 8,333 | — | $0 | 8,333 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2018-06-21 | 2018-06-26 | 33,333 | — | $0 | 33,333 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2018-06-20 | 2018-06-21 | 16,091 | $8.64 | $139.0K | 109,453 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2018-06-20 | 2018-06-21 | 33,300 | $8.64 | $287.7K | 125,544 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2018-04-20 | 2018-04-24 | 120,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2018-04-20 | 2018-04-24 | 120,000 | $1.13 | $135.6K | 120,500 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award deriv | 2018-04-06 | 2018-04-10 | 33,300 | — | $0 | 33,300 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award deriv | 2018-01-08 | 2018-01-10 | 50,000 | — | $0 | 20,000 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | A Award | 2018-01-08 | 2018-01-10 | 33,300 | — | $0 | 96,706 | SEC↗ |
| CLBS CALADRIUS BIOSCIENCES, INC | F Tax w/h | 2018-01-08 | 2018-01-10 | 4,462 | — | $0 | 92,244 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2017-12-15 | 2017-12-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2017-12-15 | 2017-12-19 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | F Tax w/h | 2017-05-18 | 2017-05-22 | 17,778 | $5.13 | $91.2K | 56,551 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | F Tax w/h | 2017-04-25 | 2017-04-27 | 690 | $4.74 | $3.3K | 74,329 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | F Tax w/h | 2017-01-25 | 2017-01-27 | 761 | $3.87 | $2.9K | 75,019 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award deriv | 2017-01-09 | 2017-01-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | F Tax w/h | 2017-01-09 | 2017-01-11 | 4,758 | $3.54 | $16.8K | 75,780 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award | 2017-01-09 | 2017-01-11 | 33,300 | — | $0 | 80,538 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2016-12-12 | 2016-12-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | F Tax w/h | 2016-10-25 | 2016-11-10 | 457 | $4.12 | $1.9K | 47,238 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award deriv | 2016-09-29 | 2016-09-30 | 50,919 | — | $0 | 50,919 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | F Tax w/h | 2016-07-25 | 2016-08-12 | 457 | $5.40 | $2.5K | 47,695 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | F Tax w/h | 2016-04-25 | 2016-05-02 | 4,545 | $0.68 | $3.1K | 458,839 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award deriv | 2016-01-25 | 2016-01-27 | 350,000 | — | $0 | 350,000 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | A Award | 2016-01-25 | 2016-01-27 | 212,800 | — | $0 | 484,478 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | F Tax w/h | 2016-01-25 | 2016-01-27 | 21,094 | $0.63 | $13.3K | 463,384 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2015-12-03 | 2015-12-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CLBS Caladrius Biosciences, Inc | P Buy | 2015-08-17 | 2015-08-18 | 20,000 | $1.40 | $28.0K | 259,543 | SEC↗ |
| NBS NeoStem, Inc. | A Award | 2015-06-02 | 2015-06-04 | 80,000 | — | $0 | 239,543 | SEC↗ |
| NBS NeoStem, Inc. | D To issuer deriv | 2015-01-16 | 2015-01-21 | 220,000 | — | $0 | 400,000 | SEC↗ |
| NBS NeoStem, Inc. | D To issuer deriv | 2015-01-16 | 2015-01-21 | 200,000 | — | $0 | 0 | SEC↗ |
| NBS NeoStem, Inc. | A Award | 2015-01-16 | 2015-01-21 | 290,078 | — | $0 | 290,078 | SEC↗ |
| NBS NeoStem, Inc. | F Tax w/h | 2015-01-16 | 2015-01-21 | 130,535 | $3.48 | $454.3K | 159,543 | SEC↗ |
| NBS NeoStem, Inc. | A Award deriv | 2015-01-05 | 2015-01-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NBS NeoStem, Inc. | A Award deriv | 2015-01-05 | 2015-01-05 | 620,000 | — | $0 | 620,000 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2014-12-11 | 2014-12-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-02-12 | 2014-02-14 | 28,900 | — | $0 | 336,394 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2014-01-01 | 2014-01-03 | 180,000 | — | $0 | 180,000 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2013-12-18 | 2013-12-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| RGDO Regado Biosciences Inc | A Award deriv | 2013-08-27 | 2013-08-29 | 558,167 | — | $0 | 558,167 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2013-02-14 | 2013-02-19 | 38,900 | — | $0 | 307,494 | SEC↗ |
| PSDV pSivida Corp. | A Award deriv | 2012-12-14 | 2012-12-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2012-02-16 | 2012-02-17 | 30,000 | — | $0 | 268,594 | SEC↗ |